Laddar...
Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial
The ENESTfreedom trial assessed the feasibility of treatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase (CML-CP) following frontline nilotinib treatment. Results for long-term outcomes after a 5-year follow-up are presented herein. Patients who had received ≥2 ye...
Sparad:
| I publikationen: | Leukemia |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group UK
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8102196/ https://ncbi.nlm.nih.gov/pubmed/33707652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-021-01205-5 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|